Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2018-11-16 Capital/Financing Update
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Result of Equity Placing
Capital/Financing Update Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the successful completion of an equity placing to raise £3.5 million, including the number of shares issued, the placing price, and details of director and substantial shareholder participation. This is a specific corporate action announcement related to capital raising, which falls under the 'Capital/Financing Update' (CAP) category. Although it is an RNS announcement, the core subject matter is a financing event, making CAP more specific than the general RNS fallback.
2018-11-16 English
Proposed Placing and Broker Option
Regulatory Filings Classification · 1% confidence The document is an official announcement released via RNS (Regulatory Information Service) on November 16, 2018. The content details a 'Proposed placing to raise £3.5 million, issue of £2.5 million Loan Notes and a broker option of up to £0.5 million' and includes a 'Business Update'. This clearly describes a significant financing activity involving the issuance of new shares and loan notes to raise capital. This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it is an RNS announcement, the primary subject matter is the capital raise, making CAP a more specific and accurate classification than the general fallback RNS.
2018-11-16 English
Unaudited Preliminary Results
Earnings Release Classification · 1% confidence The document explicitly states it contains 'Unaudited Preliminary Results for the year ended 30 June 2018'. This indicates it is a report detailing financial performance for a full fiscal year. Although it is labeled 'Preliminary', the scope covers the entire year, aligning it most closely with an Annual Report (10-K) or a comprehensive annual review. However, since it is explicitly labeled 'Preliminary Results' and is released via RNS (RNS Number : 5530H), it functions as the primary announcement of the annual figures before the final audited 10-K filing. Given the options, '10-K' is for the official yearly report, and 'ER' is for quarterly releases. Since this covers the full year, it is the annual results announcement. In many contexts, preliminary annual results announcements are classified as the precursor to the 10-K, but the content is a detailed review of the year's performance, including operational highlights, financial highlights, and management commentary (Chairman's Statement, CEO's Review). Because it is a comprehensive annual review, it fits the spirit of the Annual Report category, even if it's preliminary. Furthermore, the document mentions adopting the QCA Corporate Governance Code and discloses management/board changes, which are typical of annual reporting cycles. If it were merely an announcement of the report, it would be RPA/RNS, but the text contains the actual results summary and detailed commentary, making it the core results document for the year. Given the comprehensive nature covering the full fiscal year, I classify it as the Annual Report (10-K) equivalent for this context, recognizing it is a preliminary version released via RNS. FY 2018
2018-11-16 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details the grant of share options to a Director (Colleen Pythian) and includes specific transaction details required under Article 19(3) of the EU Market Abuse Regulation. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which maps precisely to the 'Director's Dealing' category (DIRS). Although it uses the RNS service, the specific nature of the disclosure overrides the general RNS fallback.
2018-09-10 English
Notice of GM
Regulatory Filings Classification · 1% confidence The document is explicitly labeled with an "RNS Number" and contains language typical of regulatory news service announcements from the London Stock Exchange ("This information is provided by RNS, the news service of the London Stock Exchange."). The content announces a 'Notice of General Meeting' and discusses future reporting timelines (Preliminary Results and Annual Report). Since the primary purpose of this short document is to disseminate a formal, time-sensitive corporate action notice via the regulatory news feed, it fits best under the general regulatory announcement category, RNS, rather than being the AGM material itself (AGM-R) or the future Annual Report (10-K). Given the structure and source attribution, RNS is the most appropriate classification.
2018-08-24 English
Board Appointment
Board/Management Information Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content explicitly announces the appointment of a new Non-Executive Director, Chris Yates, detailing his background and required disclosures under AIM Rules. This type of announcement, concerning changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is MANG, which takes precedence over the general RNS fallback.
2018-08-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.